Am I fully comfortable with prescribing an injectable medication outside of TGA regulations and taking full medico-legal responsibility for offering this to my patients
J Am Coll Nutr 1994;13:6-21
The past few years have transformed obesity, bringing it into the fore as one of the fastest growing therapy areas in global healthcare
With our cast of characters in place, glucose, insulin, glucagon, GLP-1, GIP, and SGLT2, we can now move into the pharmacological management of diabetes with much more context for why each medication class works the way it does
doi: 10.1007/s12035-021-02344-7
Built for Higher Stability: Cyclization (AspLys lactam bridge) plus amino-acid substitutions (e.g., Nle , D-Phe ) help reduce enzymatic breakdown in experimental systems